National Healthcare Stock Alpha and Beta Analysis

NHC Stock  USD 93.62  0.72  0.78%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as National HealthCare. It also helps investors analyze the systematic and unsystematic risks associated with investing in National HealthCare over a specified time horizon. Remember, high National HealthCare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to National HealthCare's market risk premium analysis include:
Beta
0.59
Alpha
(0.35)
Risk
1.76
Sharpe Ratio
(0.25)
Expected Return
(0.43)
Please note that although National HealthCare alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, National HealthCare did 0.35  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of National HealthCare stock's relative risk over its benchmark. National HealthCare has a beta of 0.59  . As returns on the market increase, National HealthCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding National HealthCare is expected to be smaller as well. At present, National HealthCare's Tangible Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.96, whereas Enterprise Value Over EBITDA is forecasted to decline to 5.75.

National HealthCare Quarterly Cash And Equivalents

100.31 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out National HealthCare Backtesting, National HealthCare Valuation, National HealthCare Correlation, National HealthCare Hype Analysis, National HealthCare Volatility, National HealthCare History and analyze National HealthCare Performance.
For information on how to trade National Stock refer to our How to Trade National Stock guide.

National HealthCare Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. National HealthCare market risk premium is the additional return an investor will receive from holding National HealthCare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in National HealthCare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate National HealthCare's performance over market.
α-0.35   β0.59

National HealthCare expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of National HealthCare's Buy-and-hold return. Our buy-and-hold chart shows how National HealthCare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

National HealthCare Market Price Analysis

Market price analysis indicators help investors to evaluate how National HealthCare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading National HealthCare shares will generate the highest return on investment. By understating and applying National HealthCare stock market price indicators, traders can identify National HealthCare position entry and exit signals to maximize returns.

National HealthCare Return and Market Media

The median price of National HealthCare for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 100.71 with a coefficient of variation of 9.06. The daily time series for the period is distributed with a sample standard deviation of 9.33, arithmetic mean of 102.95, and mean deviation of 7.42. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 8000 shares by Timothy Shelly of National HealthCare at 94.1 subject to Rule 16b-3
12/13/2024
2
Disposition of 100 shares by Stephen Flatt of National HealthCare subject to Rule 16b-3
12/30/2024
3
Disposition of 361 shares by Vicki Dodson of National HealthCare at 107.56 subject to Rule 16b-3
12/31/2024
4
SHAREHOLDER ALERT Kaskela Law LLC Announces Investigation of National HealthCare Corporation and Encourages Long-Term Shareholders to Contact the Firm
02/19/2025
5
Disposition of 1745 shares by J Abernathy of National HealthCare at 71.64 subject to Rule 16b-3
02/20/2025
6
Disposition of 1886 shares by Trail Sandra Y. of National HealthCare at 69.19 subject to Rule 16b-3
02/24/2025
7
Acquisition by Brian Kidd of 13500 shares of National HealthCare at 90.62 subject to Rule 16b-3
02/26/2025
8
National HealthCare Q4 Earnings Snapshot
02/27/2025
9
Record Entries For 2025 National Horseplayers Championship In Las Vegas
03/13/2025

About National HealthCare Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including National or other stocks. Alpha measures the amount that position in National HealthCare has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2024 2025 (projected)
Dividend Yield0.03770.02230.043
Price To Sales Ratio0.851.280.64

National HealthCare Upcoming Company Events

As portrayed in its financial statements, the presentation of National HealthCare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National HealthCare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of National HealthCare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of National HealthCare. Please utilize our Beneish M Score to check the likelihood of National HealthCare's management manipulating its earnings.
16th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with National HealthCare

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:
National HealthCare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of National HealthCare technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of National HealthCare trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...